Literature DB >> 9021155

Sequence variation and chromosomal mapping of the murine Cdkn2a tumor suppressor gene.

C R Herzog1, M You.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9021155     DOI: 10.1007/s003359900352

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


× No keyword cloud information.
  13 in total

1.  Allelic loss of distal chromosome 4 in mouse lung tumors localize a putative tumor suppressor gene to a region homologous with human chromosome 1p36.

Authors:  C R Herzog; Y Wang; M You
Journal:  Oncogene       Date:  1995-11-02       Impact factor: 9.867

2.  Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors.

Authors:  C R Herzog; R W Wiseman; M You
Journal:  Cancer Res       Date:  1994-08-01       Impact factor: 12.701

3.  A novel p16INK4A transcript.

Authors:  L Mao; A Merlo; G Bedi; G I Shapiro; C D Edwards; B J Rollins; D Sidransky
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

4.  Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells.

Authors:  C R Herzog; E V Soloff; A L McDoniels; F L Tyson; A M Malkinson; A Haugen-Strano; R W Wiseman; M W Anderson; M You
Journal:  Oncogene       Date:  1996-11-07       Impact factor: 9.867

Review 5.  Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.

Authors:  P M Pollock; J V Pearson; N K Hayward
Journal:  Genes Chromosomes Cancer       Date:  1996-02       Impact factor: 5.006

6.  Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest.

Authors:  D E Quelle; F Zindy; R A Ashmun; C J Sherr
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

7.  Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers.

Authors:  T Nobori; K Miura; D J Wu; A Lois; K Takabayashi; D A Carson
Journal:  Nature       Date:  1994-04-21       Impact factor: 49.962

8.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Authors:  M Serrano; G J Hannon; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

9.  Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB.

Authors:  G A Otterson; R A Kratzke; A Coxon; Y W Kim; F J Kaye
Journal:  Oncogene       Date:  1994-11       Impact factor: 9.867

10.  Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation.

Authors:  M E Hegi; T R Devereux; W F Dietrich; C J Cochran; E S Lander; J F Foley; R R Maronpot; M W Anderson; R W Wiseman
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701

View more
  4 in total

1.  An AC-repeat adjacent to mouse Cdkn2B allows the detection of specific allelic losses in the p15INK4b and p16INK4a tumor suppressor genes.

Authors:  M Malumbres; I Pérez de Castro; J Santos; R Pérez-Ollé; J Fernández-Piqueras; A Pellicer
Journal:  Mamm Genome       Date:  1998-03       Impact factor: 2.957

2.  Identification of candidate lung cancer susceptibility genes in mouse using oligonucleotide arrays.

Authors:  W J Lemon; H Bernert; H Sun; Y Wang; M You
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

3.  Microarray analysis distinguishes differential gene expression patterns from large and small colony Thymidine kinase mutants of L5178Y mouse lymphoma cells.

Authors:  Tao Han; Jianyong Wang; Weida Tong; Martha M Moore; James C Fuscoe; Tao Chen
Journal:  BMC Bioinformatics       Date:  2006-09-06       Impact factor: 3.169

4.  CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3.

Authors:  Lei Yang; Yi Chen; Ning Liu; Yanwen Lu; Wenliang Ma; Zhenhao Yang; Weidong Gan; Dongmei Li
Journal:  Mol Cancer       Date:  2022-01-18       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.